List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 66 studies with search of:   "Poliomyelitis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV
Conditions: Poliomyelitis;   Polio
Interventions: Biological: Poliomyelitis Vaccine inactivated;   Biological: Poliomyelitis Vaccine in Dragee Candy (Human Diploid Cell)
2 Completed REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-Old Children
Conditions: Diphtheria;   Tetanus;   Poliomyelitis
Interventions: Biological: REVAXIS®;   Biological: DT-Polio®
3 Completed Study of "Post-Polio Syndrome"
Conditions: Poliomyelitis;   Postpoliomyelitis Syndrome
Intervention:
4 Recruiting Immunogenicity and Safety of Adacel Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: TdcP-IPV vaccine
5 Completed Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine
Condition: Poliomyelitis
Interventions: Biological: Vaccination with inactivated polio vaccine;   Procedure: Collection of serum
6 Active, not recruiting Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly
Condition: Poliomyelitis
Interventions: Biological: Inactivated Poliomyelitis vaccine (IMOVAX);   Biological: Inactivated Poliomyelitis vaccine (IMOVAX)
7 Completed Safety of Imovax Polio in Chinese Infants and Children
Condition: Poliomyelitis
Interventions: Biological: Inactivated Poliomyelitis vaccine;   Biological: Inactivated Poliomyelitis vaccine
8 Completed Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)
Condition: Post Polio Syndrome, PPS
Intervention: Drug: Xepol
9 Completed Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: Boostrix-Polio
10 Completed Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Polio
Intervention: Drug: Boostrix polio
11 Recruiting Study of Mental Fatigue in Polio Survivors
Condition: Post-Poliomyelitis Syndrome
Intervention:
12 Completed Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Poliomyelitis
Intervention: Biological: V501, Gardasil, human papillomavirus (types 6, 11, 16, 18) recombinant vaccine / Duration of Treatment 7 Months
13 Enrolling by invitation Study of the DTacP-IPV-HepB-PRP-T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis;   Haemophilus Influenzae Type B
Intervention: Biological: DTaP-IPV-HB-PRP~T vaccine
14 Completed Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B
Interventions: Biological: DTaP-IPV-HB-PRP~T combined vaccine;   Biological: DTaP-IPV//PRP~T combined vaccine
15 Active, not recruiting Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand
Conditions: Diphtheria;   Tetanus;   Poliomyelitis;   Haemophilus Infections;   Pertussis
Intervention: Biological: Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib Vac
16 Active, not recruiting Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Haemophilus Influenzae Type B
Interventions: Biological: PEDIACEL® and Prevenar®;   Biological: Infanrix®-IPV+Hib and Prevenar®
17 Active, not recruiting Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
Conditions: Meningococcal Meningitis;   Tetanus;   Diphtheria;   Pertussis;   Poliomyelitis
Interventions: Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine;   Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine;   Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine
18 Active, not recruiting Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis
Interventions: Biological: DTaP-IPV-HB-PRP~T vaccine;   Biological: DTaP-IPV-HB-PRP~T vaccine;   Biological: DTaP-IPV-HB-PRP~T vaccine;   Biological: DTaP-HBV-IPV vaccine
19 Completed Post-Marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
Conditions: Pertussis;   Diphtheria;   Tetanus;   Poliomyelitis
Intervention: Biological: Immunization with REPEVAX® or COVAXiS™ and IPV Merieux™"
20 Active, not recruiting Immunogenicity and Safety of Pentaxim in South African Infants
Conditions: Diphtheria;   Tetanus;   Haemophilus Infections;   Pertussis;   Poliomyelitis
Intervention: Biological: Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services